These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5674126)

  • 21. [Comparative study between CPK, LDH and their isoenzymes in the detection of carriers of Duchenne's type muscular dystrophy].
    Castro-Gago M; Rodríguez-Segade S; Paz M; Novo I; Pombo M; Tojo R
    An Esp Pediatr; 1985 Sep; 23(3):170-4. PubMed ID: 4073685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.
    Zatz M; Shapiro LJ; Campion DS; Oda E; Kaback MM
    J Neurol Sci; 1978 May; 36(3):349-62. PubMed ID: 681967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum creatine phosphokinase in muscular dystrophy during iodinated amino acid therapy.
    Danowski TS; Balcerzak SP; Sabeh G; Vester JW
    Metabolism; 1969 Jan; 18(1):1-5. PubMed ID: 4885057
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum creatine kinase activity in patients with Duchenne-type dystrophy and in their mothers following physical effort].
    Hetnarska L
    Neurol Neurochir Pol; 1971; 5(5):653-7. PubMed ID: 5161075
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electron spin resonance investigations of membrane proteins in erythrocytes in muscle diseases. Duchenne and myotonic muscular dystrophy and congenital myotonia.
    Butterfield DA
    Biochim Biophys Acta; 1977 Oct; 470(1):1-7. PubMed ID: 197998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of muscular dystrophies.
    Rowland LP
    Arch Neurol; 1976 May; 33(5):315-21. PubMed ID: 773351
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for Duchenne muscular dystrophy.
    Dubowitz V
    Arch Dis Child; 1976 Apr; 51(4):249-51. PubMed ID: 776092
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of creatine phosphokinase isoenzymes of serum and cerebrospinal fluid in a patient with duchenne muscular dystrophy.
    Banerji AP; Khopkar PP; Deshpande DH; Desai AD
    Clin Chim Acta; 1973 Feb; 43(3):431-4. PubMed ID: 4120560
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 34. (Ca++ + Mg++)-ATPase of red cells in Duchenne and myotonic dystrophy.
    Ruitenbeek W; Scholte HR
    Neurology; 1980 Oct; 30(10):1132-4. PubMed ID: 6448361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biochemistry of myopathies].
    Heyck H; Laudahn G
    Hippokrates; 1967 Dec; 38(23):909-22. PubMed ID: 4891060
    [No Abstract]   [Full Text] [Related]  

  • 36. Creatine phosphokinase in facioscapulohumeral muscular dystrophy.
    Hughes BP
    Br Med J; 1971 Aug; 3(5772):464-5. PubMed ID: 5567771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic counseling in myotonia and muscular dystrophy].
    Becker PE
    Internist (Berl); 1978 Aug; 19(8):475-81. PubMed ID: 357337
    [No Abstract]   [Full Text] [Related]  

  • 38. Steroid-induced CPK estimation--a new diagnostic test for human muscular dystrophy and its carrier state.
    Sen S; Das PK
    Arch Dis Child; 1978 Jun; 53(6):521-2. PubMed ID: 686785
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythrocyte flexibility, ATPase activities and Ca efflux in patients with Duchenne muscular dystrophy, myotonic muscular dystrophy and congenital myotonia.
    Johnsson R; Somer H; Karli P; Saris NE
    J Neurol Sci; 1983 Mar; 58(3):399-407. PubMed ID: 6221082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Discussion remarks on the work of C.M.Büsing, H. Heyck and G.G. Laudahn: "The detection of female transmitters of the Duchenne type progressive muscular dystrophy by means of discriminative analysis of various serum enzyme activities"].
    Barthelmai W
    Klin Wochenschr; 1970 Apr; 48(8):497. PubMed ID: 5519403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.